List of Tables
    Table 1. Antihypertensive Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Antihypertensive Drugs Market Trends
    Table 3. Antihypertensive Drugs Market Drivers
    Table 4. Antihypertensive Drugs Market Challenges
    Table 5. Antihypertensive Drugs Market Restraints
    Table 6. Global Antihypertensive Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Antihypertensive Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Antihypertensive Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Antihypertensive Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Antihypertensive Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Antihypertensive Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Antihypertensive Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Antihypertensive Drugs Sales by Manufacturer, (M Pcs), 2017-2022
    Table 14. Global Antihypertensive Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Antihypertensive Drugs Price by Manufacturer (2017-2022) & (USD/K Pcs)
    Table 16. Global Antihypertensive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Antihypertensive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihypertensive Drugs as of 2021)
    Table 18. Top Players of Antihypertensive Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Antihypertensive Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Antihypertensive Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Antihypertensive Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Antihypertensive Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Antihypertensive Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Antihypertensive Drugs Sales by Players, (M Pcs), 2020, 2021 & 2022
    Table 26. United States Antihypertensive Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Antihypertensive Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Antihypertensive Drugs Sales in Volume by Region (2017-2022) & (M Pcs)
    Table 29. Global Antihypertensive Drugs Sales in Volume Forecast by Region (2023-2028) & (M Pcs)
    Table 30. Global Antihypertensive Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Antihypertensive Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Antihypertensive Drugs Sales in Volume by Country (2017-2028) & (M Pcs)
    Table 33. North America Antihypertensive Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Antihypertensive Drugs Sales in Volume by Region (2017-2028) & (M Pcs)
    Table 35. Asia Pacific Antihypertensive Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Antihypertensive Drugs Sales in Volume by Country (2017-2028) & (M Pcs)
    Table 37. Europe Antihypertensive Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Antihypertensive Drugs Sales in Volume by Country (2017-2028) & (M Pcs)
    Table 39. Latin Americaa Antihypertensive Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Antihypertensive Drugs Sales in Volume by Country (2017-2028) & (M Pcs)
    Table 41. Middle East and Africa Antihypertensive Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Novartis Corporation Information
    Table 43. Novartis Description and Business Overview
    Table 44. Novartis Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 45. Novartis Antihypertensive Drugs Product
    Table 46. Novartis Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Johnson & Johnson Corporation Information
    Table 53. Johnson & Johnson Description and Business Overview
    Table 54. Johnson & Johnson Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 55. Johnson & Johnson Product
    Table 56. Johnson & Johnson Recent Development
    Table 57. Sanofi Corporation Information
    Table 58. Sanofi Description and Business Overview
    Table 59. Sanofi Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 60. Sanofi Product
    Table 61. Sanofi Recent Development
    Table 62. Lupin Corporation Information
    Table 63. Lupin Description and Business Overview
    Table 64. Lupin Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 65. Lupin Product
    Table 66. Lupin Recent Development
    Table 67. Ranbaxy Laboratories Corporation Information
    Table 68. Ranbaxy Laboratories Description and Business Overview
    Table 69. Ranbaxy Laboratories Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 70. Ranbaxy Laboratories Product
    Table 71. Ranbaxy Laboratories Recent Development
    Table 72. Merck Corporation Information
    Table 73. Merck Description and Business Overview
    Table 74. Merck Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 75. Merck Product
    Table 76. Merck Recent Development
    Table 77. Astra Zeneca Corporation Information
    Table 78. Astra Zeneca Description and Business Overview
    Table 79. Astra Zeneca Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 80. Astra Zeneca Product
    Table 81. Astra Zeneca Recent Development
    Table 82. Daiichi Sankyo Corporation Information
    Table 83. Daiichi Sankyo Description and Business Overview
    Table 84. Daiichi Sankyo Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 85. Daiichi Sankyo Product
    Table 86. Daiichi Sankyo Recent Development
    Table 87. Takeda Corporation Information
    Table 88. Takeda Description and Business Overview
    Table 89. Takeda Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 90. Takeda Product
    Table 91. Takeda Recent Development
    Table 92. Actelion Corporation Information
    Table 93. Actelion Description and Business Overview
    Table 94. Actelion Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 95. Actelion Product
    Table 96. Actelion Recent Development
    Table 97. United Therapeutics Corporation Information
    Table 98. United Therapeutics Description and Business Overview
    Table 99. United Therapeutics Antihypertensive Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2017-2022)
    Table 100. United Therapeutics Product
    Table 101. United Therapeutics Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Antihypertensive Drugs Customers List
    Table 105. Antihypertensive Drugs Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antihypertensive Drugs Product Picture
    Figure 2. Global Antihypertensive Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Antihypertensive Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Antihypertensive Drugs Sales 2017-2028 (M Pcs)
    Figure 5. United States Antihypertensive Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Antihypertensive Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Antihypertensive Drugs Sales 2017-2028 (M Pcs)
    Figure 8. United States Antihypertensive Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Antihypertensive Drugs Market Share in Global, in Volume (M Pcs) 2017-2028
    Figure 10. Antihypertensive Drugs Report Years Considered
    Figure 11. Product Picture of Diuretic Antihypertensive
    Figure 12. Product Picture of Sympathetic Suppressant
    Figure 13. Product Picture of Renin-angiotensin System Inhibitor
    Figure 14. Product Picture of Calcium Antagonist Medicine
    Figure 15. Product Picture of vasodilator
    Figure 16. Global Antihypertensive Drugs Market Share by Type in 2022 & 2028
    Figure 17. Global Antihypertensive Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Antihypertensive Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Antihypertensive Drugs Sales by Type (2017-2028) & (M Pcs)
    Figure 20. Global Antihypertensive Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Antihypertensive Drugs Price by Type (2017-2028) & (USD/K Pcs)
    Figure 22. United States Antihypertensive Drugs Market Share by Type in 2022 & 2028
    Figure 23. United States Antihypertensive Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Antihypertensive Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Antihypertensive Drugs Sales by Type (2017-2028) & (M Pcs)
    Figure 26. United States Antihypertensive Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Antihypertensive Drugs Price by Type (2017-2028) & (USD/K Pcs)
    Figure 28. Product Picture of The Old
    Figure 29. Product Picture of Pregnant Woman
    Figure 30. Product Picture of General Patient
    Figure 31. Global Antihypertensive Drugs Market Share by Application in 2022 & 2028
    Figure 32. Global Antihypertensive Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Antihypertensive Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Antihypertensive Drugs Sales by Application (2017-2028) & (M Pcs)
    Figure 35. Global Antihypertensive Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Antihypertensive Drugs Price by Application (2017-2028) & (USD/K Pcs)
    Figure 37. United States Antihypertensive Drugs Market Share by Application in 2022 & 2028
    Figure 38. United States Antihypertensive Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Antihypertensive Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Antihypertensive Drugs Sales by Application (2017-2028) & (M Pcs)
    Figure 41. United States Antihypertensive Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Antihypertensive Drugs Price by Application (2017-2028) & (USD/K Pcs)
    Figure 43. North America Antihypertensive Drugs Sales in Volume Growth Rate 2017-2028 (M Pcs)
    Figure 44. North America Antihypertensive Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Antihypertensive Drugs Sales in Volume Growth Rate 2017-2028 (M Pcs)
    Figure 48. Europe Antihypertensive Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Antihypertensive Drugs Sales in Volume Growth Rate 2017-2028 (M Pcs)
    Figure 55. Asia-Pacific Antihypertensive Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Antihypertensive Drugs Sales in Volume Growth Rate 2017-2028 (M Pcs)
    Figure 67. Latin America Antihypertensive Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Antihypertensive Drugs Sales in Volume Growth Rate 2017-2028 (M Pcs)
    Figure 72. Middle East & Africa Antihypertensive Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Antihypertensive Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Antihypertensive Drugs Value Chain
    Figure 77. Antihypertensive Drugs Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed